Aardvark Therapeutics, Inc. (AARD) Deep Dive Video
Summary
Aardvark is a distressed cash-backed biotech option whose upside depends on rescuing ARD-101 from an FDA clinical hold before cash burn, dilution, and Soleno’s first-mover lead overwhelm the investment thesis.